Basics |
Company: |
Sight Sciences, Inc. Common Stock |
IPO Date: |
July 12, 2021 |
Sector: |
Healthcare |
Industry: |
Medical Devices |
Market Cap: |
$127.51M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.35 | 3.63%
|
Avg Daily Range (30 D): |
$0.09 | 2.95%
|
Avg Daily Range (90 D): |
$0.11 | 2.79%
|
Institutional Daily Volume |
Avg Daily Volume: |
.21M |
Avg Daily Volume (30 D): |
.2M |
Avg Daily Volume (90 D): |
.19M |
Trade Size |
Avg Trade Size (Sh.): |
82 |
Avg Trade Size (Sh.) (30 D): |
104 |
Avg Trade Size (Sh.) (90 D): |
93 |
Institutional Trades |
Total Inst.Trades: |
120 |
Avg Inst. Trade: |
$2.35M |
Avg Inst. Trade (30 D): |
$.54M |
Avg Inst. Trade (90 D): |
$.54M |
Avg Inst. Trade Volume: |
.18M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$3.63M |
Avg Closing Trade (30 D): |
$.54M |
Avg Closing Trade (90 D): |
$.54M |
Avg Closing Volume: |
260.34K |
|
|
|
|
Financials |
|
TTM |
Q2 2024 |
Q1 2024 |
Basic EPS
|
$-.22
|
$-.25
|
$-.33
|
Diluted EPS
|
$-.22
|
$-.25
|
$-.33
|
Revenue
|
$ 20.16M
|
$ 21.37M
|
$ 19.27M
|
Gross Profit
|
$ 16.91M
|
$ 18.35M
|
$ 16.47M
|
Net Income / Loss
|
$ -11.07M
|
$ -12.33M
|
$ -16.27M
|
Operating Income / Loss
|
$ -11.23M
|
$ -12.65M
|
$ -14.72M
|
Cost of Revenue
|
$ 3.25M
|
$ 3.03M
|
$ 2.79M
|
Net Cash Flow
|
$ .39M
|
$ -9.11M
|
$ -10.85M
|
PE Ratio
|
|
|
|
|